176 related articles for article (PubMed ID: 24323376)
1. Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.
Hart BL; Taheri S; Rosenberg GA; Morrison LA
Transl Stroke Res; 2013 Oct; 4(5):500-6. PubMed ID: 24323376
[TBL] [Abstract][Full Text] [Related]
2. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
[TBL] [Abstract][Full Text] [Related]
3. Quantification of blood-to-brain transfer rate in multiple sclerosis.
Taheri S; Rosenberg GA; Ford C
Mult Scler Relat Disord; 2013 Apr; 2(2):124-32. PubMed ID: 25877634
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic imaging of hemangiomas in the brain].
Toyoda K; Oba H
Brain Nerve; 2011 Jan; 63(1):5-15. PubMed ID: 21228443
[TBL] [Abstract][Full Text] [Related]
5. Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene.
Garaci F; Marsili L; Riant F; Marziali S; Cécillon M; Pasquarelli R; Sangiuolo F; Floris R; Novelli G; Tournier-Lasserve E; Brancati F
Neuroradiol J; 2015 Jun; 28(3):289-93. PubMed ID: 26246098
[TBL] [Abstract][Full Text] [Related]
6. Does routine MR contrast enhancement correlate with internal thrombosis in cerebral cavernous malformations? A radiological-histopathological correlation in a case series.
Jensen-Kondering U; Knöss N; Dörner L; Hugo HH; Jansen O
Neurol Res; 2011 Jun; 33(5):558-9. PubMed ID: 21669128
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Lanfranconi S; Scola E; Bertani GA; Zarino B; Pallini R; d'Alessandris G; Mazzon E; Marino S; Carriero MR; Scelzo E; Faragò G; Castori M; Fusco C; Petracca A; d'Agruma L; Tassi L; d'Orio P; Lampugnani MG; Nicolis EB; Vasamì A; Novelli D; Torri V; Meessen JMTA; Al-Shahi Salman R; Dejana E; Latini R;
Trials; 2020 May; 21(1):401. PubMed ID: 32398113
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging of cerebral cavernous malformations.
Klostranec JM; Krings T
J Neurosurg Sci; 2015 Sep; 59(3):221-35. PubMed ID: 25968928
[TBL] [Abstract][Full Text] [Related]
9. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
[TBL] [Abstract][Full Text] [Related]
10. Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study.
Incerti I; Fusco M; Contarino VE; Siggillino S; Conte G; Lanfranconi S; Bertani GA; Gaudino C; d'Orio P; Pallini R; D'Alessandris QG; Meessen JMTA; Nicolis EB; Vasamì A; Dejana E; Bianchi AM; Triulzi FM; Latini R; Scola E
Eur Radiol; 2023 Jun; 33(6):4158-4166. PubMed ID: 36602570
[TBL] [Abstract][Full Text] [Related]
11. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI.
Dammann P; Wrede KH; Maderwald S; El Hindy N; Mueller O; Chen B; Zhu Y; Hütter BO; Ladd ME; Schlamann M; Sandalcioglu IE; Sure U
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):194-200. PubMed ID: 23085932
[TBL] [Abstract][Full Text] [Related]
12. Cerebral cavernous malformations with diffuse manifestation: A benign entity?
Tsutsumi S; Ogino I; Miyajima M; Arai H; Ito M; Yasumoto Y
J Neurol Sci; 2016 Aug; 367():335-41. PubMed ID: 27423615
[TBL] [Abstract][Full Text] [Related]
13. The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations.
Lidsky ME; Spritzer CE; Shortell CK
J Vasc Surg; 2012 Sep; 56(3):757-64.e1. PubMed ID: 22840741
[TBL] [Abstract][Full Text] [Related]
14. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.
Mikati AG; Tan H; Shenkar R; Li L; Zhang L; Guo X; Larsson HB; Shi C; Liu T; Wang Y; Shah A; Edelman RR; Christoforidis G; Awad I
Stroke; 2014 Feb; 45(2):598-601. PubMed ID: 24302484
[TBL] [Abstract][Full Text] [Related]
15. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.
Lehnhardt FG; von Smekal U; Rückriem B; Stenzel W; Neveling M; Heiss WD; Jacobs AH
Arch Neurol; 2005 Apr; 62(4):653-8. PubMed ID: 15824268
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar cavernous malformations with and without associated developmental venous anomalies.
Zhang P; Liu L; Cao Y; Wang S; Zhao J
BMC Neurol; 2013 Oct; 13():134. PubMed ID: 24088363
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging.
de Champfleur NM; Langlois C; Ankenbrandt WJ; Le Bars E; Leroy MA; Duffau H; Bonafé A; Jaffe J; Awad IA; Labauge P
Neurosurgery; 2011 Mar; 68(3):641-7; discussion 647-8. PubMed ID: 21164377
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age.
Brinjikji W; El-Masri AE; Wald JT; Flemming KD; Lanzino G
Childs Nerv Syst; 2017 Sep; 33(9):1539-1543. PubMed ID: 28643038
[TBL] [Abstract][Full Text] [Related]
20. Vascular permeability in cerebral cavernous malformations.
Mikati AG; Khanna O; Zhang L; Girard R; Shenkar R; Guo X; Shah A; Larsson HB; Tan H; Li L; Wishnoff MS; Shi C; Christoforidis GA; Awad IA
J Cereb Blood Flow Metab; 2015 Oct; 35(10):1632-9. PubMed ID: 25966944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
